Research

Energy balance

Achieving a weight loss of ≥5% is clinically meaningful for improving cardiometabolic risk factors and is the threshold for FDA approval of anti-obesity medications, though greater losses (≥10-15%) are required for remission of conditions like type 2 diabetes and NASH.

Aim for a 5% weight loss as a primary, achievable goal to significantly improve your heart health and metabolic markers. If you have specific conditions like Type 2 Diabetes or NASH, discuss with your doctor if a higher target (10-15%) is needed for remission, but do not let the higher target discourage you from starting with the 5% goal, which brings substantial health benefits.

GoodQualifiesHIGH confidence
Numerous studies have shown that weight loss of ≥5% results in significant improvements in cardiometabolic risk factors associated with obesity; this degree of weight loss is also required for the approval of novel anti-obesity medications by the US Food and and Drug Administration. However, some obesity-related comorbidities and complications, such as non-alcoholic steatohepatitis, obstructive sleep apnea, gastroesophageal reflux disease and remission of type 2 diabetes, require a greater magnitude of weight loss to achieve clinically meaningful improvements.
Deborah B. Horn et al. · Postgraduate Medicine · 2022

Why this rating

Based on a narrative review citing multiple clinical trials and FDA guidelines.

Source

What is clinically relevant weight loss for your patients and how can it be achieved? A narrative review

Deborah B. Horn et al. · Postgraduate Medicine · 2022

DOI 10.1080/00325481.2022.2051366

narrative_reviewCited 99×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →